Bank of New York Mellon’s Theriva Biologics TOVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-8
| Closed | -$17K | – | 4254 |
|
|
2018
Q2 | $17K | Sell |
8
-3
| -27% | -$6.38K | ﹤0.01% | 4173 |
|
|
2018
Q1 | $31K | Buy |
11
+2
| +22% | +$5.64K | ﹤0.01% | 4221 |
|
|
2017
Q4 | $38K | Buy |
9
+1
| +13% | +$4.22K | ﹤0.01% | 4220 |
|
|
2017
Q3 | $68K | Hold |
8
| – | – | ﹤0.01% | 4053 |
|
|
2017
Q2 | $41K | Sell |
8
-22
| -73% | -$113K | ﹤0.01% | 4156 |
|
|
2017
Q1 | $166K | Buy |
30
+1
| +3% | +$5.53K | ﹤0.01% | 3920 |
|
|
2016
Q4 | $196K | Hold |
29
| – | – | ﹤0.01% | 3909 |
|
|
2016
Q3 | $429K | Sell |
29
-4
| -12% | -$59.2K | ﹤0.01% | 3609 |
|
|
2016
Q2 | $525K | Buy |
33
+24
| +267% | +$382K | ﹤0.01% | 3515 |
|
|
2016
Q1 | $194K | Hold |
9
| – | – | ﹤0.01% | 3792 |
|
|
2015
Q4 | $188K | Hold |
9
| – | – | ﹤0.01% | 3859 |
|
|
2015
Q3 | $186K | Hold |
9
| – | – | ﹤0.01% | 3888 |
|
|
2015
Q2 | $230K | Hold |
9
| – | – | ﹤0.01% | 3850 |
|
|
2015
Q1 | $173K | Buy |
9
+5
| +125% | +$96.1K | ﹤0.01% | 3926 |
|
|
2014
Q4 | $54K | Hold |
4
| – | – | ﹤0.01% | 4117 |
|
|
2014
Q3 | $63K | Hold |
4
| – | – | ﹤0.01% | 4122 |
|
|
2014
Q2 | $61K | Buy |
+4
| New | +$61K | ﹤0.01% | 4058 |
|